These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7438 related articles for article (PubMed ID: 17713027)

  • 21. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens.
    Van Nuffel AM; Tuyaerts S; Benteyn D; Wilgenhof S; Corthals J; Heirman C; Neyns B; Thielemans K; Bonehill A
    J Immunol Methods; 2012 Mar; 377(1-2):23-36. PubMed ID: 22269772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
    Li HS; Liu C; Xiao Y; Chu F; Liang X; Peng W; Hu J; Neelapu SS; Sun SC; Hwu P; Watowich SS
    Sci Signal; 2016 Sep; 9(447):ra94. PubMed ID: 27678219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.
    Butterfield LH; Ribas A; Potter DM; Economou JS
    Cancer Immunol Immunother; 2007 Dec; 56(12):1931-43. PubMed ID: 17522860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte subpopulations and immunoglobulin levels in Hodgkin's disease survivors.
    Eckschlager T; Průsa R; Hladíková M; Radvanská J; Slabý K; Radvanský J
    Neoplasma; 2004; 51(4):261-4. PubMed ID: 15254656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
    Richards SJ; Scott CS
    Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
    Abo-Elenein A; Shaaban D; Gheith O
    Egypt J Immunol; 2008; 15(2):135-43. PubMed ID: 20306696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cells.
    Parrot T; Allard M; Oger R; Benlalam H; Raingeard de la Blétière D; Coutolleau A; Preisser L; Desfrançois J; Khammari A; Dréno B; Labarrière N; Delneste Y; Guardiola P; Gervois N
    Eur J Immunol; 2016 Jul; 46(7):1770-82. PubMed ID: 27094152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subpopulation composition of peripheral blood lymphocytes in children with infectious mononucleosis.
    Novitskii VV; Urazova OI; Naslednikova IO; Pomogaeva AP; Syusina LV
    Bull Exp Biol Med; 2002 Jul; 134(1):57-9. PubMed ID: 12459870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness evaluation of dendritic cell immunotherapy for osteosarcoma on survival rate and in vitro immune response.
    Fang X; Jiang C; Xia Q
    Genet Mol Res; 2015 Oct; 14(4):11763-70. PubMed ID: 26436501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4
    Di Gennaro P; Gerlini G; Urso C; Sestini S; Brandani P; Pimpinelli N; Borgognoni L
    Clin Exp Metastasis; 2016 Dec; 33(8):787-798. PubMed ID: 27475809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy for melanoma: the good, the bad, and the future.
    Poehlein CH; Rüttinger D; Ma J; Hu HM; Urba WJ; Fox BA
    Curr Oncol Rep; 2005 Sep; 7(5):383-92. PubMed ID: 16091201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.
    Wei Y; Sticca RP; Holmes LM; Burgin KE; Li J; Williamson J; Evans L; Smith SJ; Stephenson JJ; Wagner TE
    Int J Oncol; 2006 Mar; 28(3):585-93. PubMed ID: 16465362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
    Mansour I; Doinel C; Rouger P
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
    Trakatelli M; Toungouz M; Blocklet D; Dodoo Y; Gordower L; Laporte M; Vereecken P; Sales F; Mortier L; Mazouz N; Lambermont M; Goldman S; Coulie P; Goldman M; Velu T
    Cancer Immunol Immunother; 2006 Apr; 55(4):469-74. PubMed ID: 16133111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 372.